Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura W Dillon

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
American Journal of Hematology|March 13, 2020
Microtransplantation in older patients with AML: A pilot study of safety, efficacy and immunologic effectsAnthony D Sung, Shekeab Jauhari, Sharareh Siamakpour-Reihani, et al.
Blood Cancer Discovery|July 14, 2021
Personalized Single-Cell Proteogenomics to Distinguish Acute Myeloid Leukemia from Non-Malignant Clonal HematopoiesisLaura W Dillon, Jack Ghannam, Chidera Nosiri, et al.
JAMA Oncology|May 2, 2024
Measurable Residual FLT3 Internal Tandem Duplication Before Allogeneic Transplant for Acute Myeloid LeukemiaLaura W Dillon, Gege Gui, Niveditha Ravindra, et al.
Bone Marrow Transplantation|November 6, 2024
Measurable residual mutated IDH1 before allogeneic transplant for acute myeloid leukemiaGege Gui, Niveditha Ravindra, Pranay S Hegde, et al.
Blood|November 14, 2025
CPX-351 versus daunorubicin, cytarabine plus gemtuzumab ozogamicin in older adults with non-adverse risk AML: NCRI AML18Steven Knapper, Laura W Dillon, Malavika Babu, et al.
Bone Marrow Transplantation|October 25, 2024
Measurable residual mutated IDH2 before allogeneic transplant for acute myeloid leukemiaGege Gui, Niveditha Ravindra, Pranay S Hegde, et al.
Bone Marrow Transplantation|November 25, 2025
Measurable residual mutated NPM1 before allogeneic transplant for acute myeloid leukemiaRasha W Al-Ali, Gege Gui, Niveditha Ravindra, et al.
Blood Advances|February 10, 2025
Randomized phase 2 study to assess the role of single-agent nivolumab to maintain remission in acute myeloid leukemiaAthalia R Pyzer, Laura W Dillon, Elad Sharon, et al.
The New England Journal of Medicine|October 27, 2020
Somatic Mutations in <i>UBA1</i> and Severe Adult-Onset Autoinflammatory DiseaseDavid B Beck, Marcela A Ferrada, Keith A Sikora, et al.
Medrxiv : the Preprint Server for Health Sciences|December 17, 2025
Genomics of Acute Myeloid Leukemia at Diagnosis and RemissionKai Yu, Laura W Dillon, Jesse M Tettero, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
American Journal of Hematology|March 13, 2020
Microtransplantation in older patients with AML: A pilot study of safety, efficacy and immunologic effectsAnthony D Sung, Shekeab Jauhari, Sharareh Siamakpour-Reihani, et al.
Blood Cancer Discovery|July 14, 2021
Personalized Single-Cell Proteogenomics to Distinguish Acute Myeloid Leukemia from Non-Malignant Clonal HematopoiesisLaura W Dillon, Jack Ghannam, Chidera Nosiri, et al.
JAMA Oncology|May 2, 2024
Measurable Residual FLT3 Internal Tandem Duplication Before Allogeneic Transplant for Acute Myeloid LeukemiaLaura W Dillon, Gege Gui, Niveditha Ravindra, et al.
Bone Marrow Transplantation|November 6, 2024
Measurable residual mutated IDH1 before allogeneic transplant for acute myeloid leukemiaGege Gui, Niveditha Ravindra, Pranay S Hegde, et al.
Blood|November 14, 2025
CPX-351 versus daunorubicin, cytarabine plus gemtuzumab ozogamicin in older adults with non-adverse risk AML: NCRI AML18Steven Knapper, Laura W Dillon, Malavika Babu, et al.
Bone Marrow Transplantation|October 25, 2024
Measurable residual mutated IDH2 before allogeneic transplant for acute myeloid leukemiaGege Gui, Niveditha Ravindra, Pranay S Hegde, et al.
Bone Marrow Transplantation|November 25, 2025
Measurable residual mutated NPM1 before allogeneic transplant for acute myeloid leukemiaRasha W Al-Ali, Gege Gui, Niveditha Ravindra, et al.
Blood Advances|February 10, 2025
Randomized phase 2 study to assess the role of single-agent nivolumab to maintain remission in acute myeloid leukemiaAthalia R Pyzer, Laura W Dillon, Elad Sharon, et al.
The New England Journal of Medicine|October 27, 2020
Somatic Mutations in <i>UBA1</i> and Severe Adult-Onset Autoinflammatory DiseaseDavid B Beck, Marcela A Ferrada, Keith A Sikora, et al.
Medrxiv : the Preprint Server for Health Sciences|December 17, 2025
Genomics of Acute Myeloid Leukemia at Diagnosis and RemissionKai Yu, Laura W Dillon, Jesse M Tettero, et al.
Pageof 5